Back to results
US 2014/0228342 A1Published application
Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics
AssigneeGalderma Research & Development
InventorClaire Bouix-Peter
Life of this patent
Estimating the term…
Abstract
Methods for treating hypopigmentary pathologies and photosensitive dermatoses are described. Also described, are compounds that are agonists of the MCIR receptor and that exhibit reduced toxicity relative to other compounds of the same class. These compounds can have the general formula (I) wherein: R1 represents a cyclopropylmethyl or a 4-hydroxybutyl group; R2 represents a hydrogen atom or a methyl group; and also the salts and enantiomers of the corresponding compounds of general formula (I).
Claims18
A compound of general formula (I) below:
- in which:
- R1 represents a cyclopropylmethyl or a 4-hydroxybutyl group;
- R2 represents a hydrogen atom or a methyl group;
- and also salts and enantiomers of the corresponding compounds of general formula (I).
1 more element
Dependencies are inferred from the claim text.